FDA held several public and stakeholder meetings, including May 27-28 public meeting
and December 4 stakeholder meeting, to discuss opioid risks, misuse, and abuse.
FDA partnered with U.S. Substance Abuse and Mental Health Services Administration
(SAMHSA) to launch an initiative to help ensure the safe use of the opioid methadone.
FDA launched the Safe Use Initiative to reduce preventable harm by medications, including opioids. FDA began working with U.S. Drug Enforcement Administration (DEA) and others to help educate the public on safe disposal of opioids.